Trial NCT00443703

View at ClinicalTrials.gov 
Org. Study IDs: 0518-032
Secondary IDs: 2007_507

Last trial update was posted on 2017-03-21

MeSH Interventions

Lopinavir Raltegravir Potassium Ritonavir

MeSH Conditions

HIV Infections

Other Conditions

HIV Infection

Stopping Reasons

primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus lopinavir (+) ritonavir

Limitations And Caveats

The reason for early termination: Study was terminated after the primary efficacy analysis at Week 24 did not demonstrate non-inferiority of MK0518 versus KALETRA™.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID